RLX Technology Extends Share Repurchase Program Through 2027, Authorizing $500 Million

RLX
December 31, 2025

RLX Technology Inc. extended its share‑repurchase program through December 31 2027, authorizing a total of $500 million for buybacks and leaving $170 million of the original program unused.

The extension permits an additional $170 million to be repurchased, bringing the total authorized amount to $500 million. The company has already repurchased 170 million shares for $330 million, leaving $170 million of the original program available for future buybacks.

The program is funded from the company’s cash balance, underscoring a strong liquidity position with a current ratio of 9.3. The extension signals management’s confidence in the company’s financial health and its ability to return capital while pursuing growth initiatives.

RLX’s Q3 2025 results showed a 49% year‑over‑year increase in net revenues to $1.129 billion, driven largely by international markets that now account for 70‑80% of revenue. CEO Kate Wang highlighted disciplined execution on international expansion and product innovation as key drivers of the growth.

CFO Chao Lu noted that the company’s focus on international markets and new product categories—such as refillable pod systems and eco‑friendly offerings—has helped offset regulatory headwinds in core regions. The share‑repurchase extension aligns with the company’s strategy to balance shareholder returns with continued investment in high‑growth opportunities.

The extension also provides strategic flexibility, allowing RLX to maintain a robust buyback program while allocating capital to product development and market expansion. The move reinforces the company’s commitment to shareholder value amid a dynamic e‑vapor industry.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.